ERIN ESAKI: Open Payments
NPI 1023611100 · PLEASANT HILL, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$423 in 12 payments from 8 companies in 2025. Trend: 2023 $2,936 · 2024 $937 · 2025 $423
Food & beverage: $423
| Company | Payments | Amount |
|---|---|---|
| STERIS CORPORATION | 1 | $158 |
| GlaxoSmithKline, LLC. | 4 | $116 |
| E.R. Squibb & Sons, L.L.C. | 2 | $43 |
| Merck Sharp & Dohme LLC | 1 | $29 |
| Daiichi Sankyo Inc. | 1 | $21 |
| Celgene Corporation | 1 | $19 |
| Aadi Bioscience, Inc. | 1 | $18 |
| PFIZER INC. | 1 | $18 |
Products named: JEMPERLI, OPDIVO, KEYTRUDA, Enhertu, REBLOZYL, Fyarro, TIVDAK.
Industry payments across CA — which companies pay providers there.
